Mitochondria-targeted antioxidants: a step towards disease treatment
In 1982, they published a paper in the Proceedings of the National Academy of Sciences (PNAS), revealing that the glucagon precursor gene actually encodes three peptides-glucagon and two new hormones expressed in the intestine.20 A year later, a research team led by Graeme Bell from Chiron Corporation published two papers in the journal Nature.21,22 They cloned and sequenced the preproglucagon gene, discovering GLP-1 and GLP-2 hormones
Constipation
G2/M cell cycle arrest and downregulation of Nf-kB/m-TOR/PI3K/AKT pathway
Table 1 Summary of the changes in intra-portal insulin levels in different disease states, after weight loss and after drug therapy on the GH/IGF-I axis
Its SUSTAIN (diabetes) and STEP (obesity) trial programs produced landmark data on glycemic control, cardiovascular outcomes, renal protection, and weight reduction